Advancing Synovial Sarcoma Care: Exploring Innovations in Targeted Therapies - Episode 1
Panelists discuss how synovial sarcoma is a rare soft-tissue cancer characterized by its unique SS18::SSX fusion oncogene transcript, which distinguishes it from other sarcomas and drives its aggressive behavior through altered epigenetic regulation, despite its misleading name suggesting origin in synovial tissue.
Video content above is prompted by the following: